Indaptus Therapeutics, Inc. (INDP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.81M |
| Enterprise Value | -5.7M |
| P/E Ratio | -0.59 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.44 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -8.65 |
| Return On Equity | -10.29 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.85M |
| Net Income | -20.85M |
| Diluted EPS | -21.58 |
| Total Cash | 1.5M |
| Total Cash/Share | 0.69 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.34 |
| Book Value Per Share | 0.58 |
| 52-Week Change | -73.5 |
| 52-Week High | 14.84 |
| 52-Week Low | 0.92 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 2.52 |
| Average Volume | 1M |
| Shares Outstanding | 1.75M |
| % Held by Institutions | 3.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:28 |
| Last Split Date | June 27, 2025 |